WoodcockJ., and MarksP.Drug regulation in the era of individualized therapies. N. Engl. J. Med. 381:1678–1680, 2019.
2.
HermanA.Why operation warp speed worked. Wall St. J. 4 Feb 2021.
3.
SlaouiM., GreeneS.E., and WoodcockJ.Bridging the gap at warp speed—delivering options for preventing and treating Covid-19. N. Engl. J. Med. 383:1899–1901, 2020.
4.
YoonD.J., KaurR., GallegosA., et al.Adverse effects of topical timolol: safety concerns and implications for dermatologic use. J. Am. Acad. Dermatol. 84:199–200, 2021.
5.
Anonymous. Termination of the Food and Drug Administration's Unapproved Drugs Initiative; Request for Information Regarding Drugs Potentially Generally Recognized as Safe and Effective. Fed. Reg. 85:75331–75334, 2020.
